secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aspire Biopharma Holdings, Inc. (ASBP)
CIK:        0001847345
Form:       8-K
Filed at:   2023-05-04T23:59:59+00:00
Accession:  0001104659-23-056027
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

PowerUp Acquisition trust balance stands at $303.3M ($10.55/share) as of May 3, 2023
--------------------------------------------------------------------------------

- Trust account held at Citibank with American Stock Transfer as trustee; balance $303,324,683.
- Per-share trust value of $10.55 for public shares, updated ahead of extension vote.
- Company filed Definitive Proxy Statement on April 21, 2023 for Extension Amendment Proposal.
- Proceeds from IPO remain in trust pending potential business combination or extension.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1847345/000110465923056027/0001104659-23-056027-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1847345/000110465923056027/tm2314762d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-056027

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer